Literature DB >> 17997174

High-sensitivity C-reactive protein is associated with the risk of coronary heart disease as estimated by the Framingham Risk Score in middle-aged Japanese men.

Toshiaki Otsuka1, Tomoyuki Kawada, Masao Katsumata, Chikao Ibuki, Yoshiki Kusama.   

Abstract

BACKGROUND: High-sensitivity C-reactive protein (hsCRP) has emerged as an independent predictor of coronary heart disease (CHD) in Western countries. However, it is still uncertain regarding whether hsCRP is associated with the risk of CHD in Japan.
METHODS: The serum hsCRP levels were measured in 687 middle-aged Japanese male workers (age range; 40-59 years) during an annual health examination at a company in Kanagawa, Japan, in 2005. All participants were free from any cardiovascular diseases and any medications for hypertension, hyperlipidemia, or diabetes. The Framingham Risk Score (FRS) was calculated as an individual's risk level of future development of CHD. Associations between hsCRP and the FRS were then evaluated.
RESULTS: The distribution of hsCRP was skewed to the left with a median value (interquartile range) of 0.3 (0.2, 0.6) mg/L. Log-transformed hsCRP significantly correlated with all components of the FRS except for age. The FRS gradually and significantly increased (p=0.001 for trend) with an increase in the quartiles of hsCRP after adjusting for multiple potential confounders such as triglycerides, the body mass index, alcohol intake, and a family history of cardiovascular disease. For the highest quartile of hsCRP, crude and above-listed confounders-adjusted odds ratios of the high-risk for CHD (FRS>/=6 point) compared to the lowest quartile were 6.97 (95% CI: 3.20-15.17, p<0.001) and 3.85 (95% CI: 1.69-8.77, p=0.001), respectively.
CONCLUSIONS: These results suggest that hsCRP is associated with the risk of CHD, as estimated by the FRS, in middle-aged Japanese men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997174     DOI: 10.1016/j.ijcard.2007.07.099

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China.

Authors:  Angela M Thompson; Yonghong Zhang; Weijun Tong; Tan Xu; Jing Chen; Li Zhao; Tanika N Kelly; Chung-Shiuan Chen; Lydia A Bazzano; Jiang He
Journal:  Int J Cardiol       Date:  2010-05-01       Impact factor: 4.164

2.  C-reactive protein in relation to early atherosclerosis and periodontitis.

Authors:  Maha Yakob; Jukka H Meurman; Tomas Jogestrand; Jacek Nowak; Per-Östen Söder; Birgitta Söder
Journal:  Clin Oral Investig       Date:  2010-12-07       Impact factor: 3.573

3.  Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease.

Authors:  Yali Zheng; Wenfei Ma; Yan Zeng; Jiani Liu; Shan Ye; Shaohua Chen; Ling Lan; Raimund Erbel; Qigong Liu
Journal:  Clin Res Cardiol       Date:  2009-09-18       Impact factor: 5.460

4.  Apolipoprotein B is highly associated with the risk of coronary heart disease as estimated by the Framingham risk score in healthy Korean men.

Authors:  Jae-Hong Ryoo; Eun-Hee Ha; Soo-Geun Kim; Seungho Ryu; Da-Woon Lee
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

5.  Association of high-sensitivity C-reactive protein in middle-aged and elderly Chinese people with hyperuricaemia and risk of coronary heart disease: a cross-sectional study.

Authors:  Mingsheng Xie; Dongxing Xie; Xiang Ding; Hui Li; Ye Yang; Yi Zhang; Kun Li; Bin Zhou; Zidan Yang
Journal:  BMJ Open       Date:  2019-10-18       Impact factor: 2.692

6.  Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.

Authors:  Norihito Takahashi; Tomotaka Dohi; Hirohisa Endo; Takehiro Funamizu; Hideki Wada; Shinichiro Doi; Yoshiteru Kato; Manabu Ogita; Iwao Okai; Hiroshi Iwata; Shinya Okazaki; Kikuo Isoda; Katsumi Miyauchi; Kazunori Shimada
Journal:  J Clin Med       Date:  2020-04-06       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.